Methodological and practical challenges for personalized cancer therapies (Q37848661)

24 August 2017

1 reference

title

Methodological and practical challenges for personalized cancer therapies (English)

1 reference

24 August 2017

1

Ignacio I Wistuba

1 reference

24 August 2017

5

Roy S Herbst

1 reference

24 August 2017

Juri G Gelovani

2

1 reference

24 August 2017

Jörg J Jacoby

series ordinal

3

1 reference

24 August 2017

Suzanne E Davis

series ordinal

4

1 reference

24 August 2017

language of work or name

English

0 references

publication date

1 March 2011

1 reference

Nature Reviews Clinical Oncology

24 August 2017

1 reference

24 August 2017

8

1 reference

24 August 2017

3

1 reference

24 August 2017

135-141

1 reference

Progress in childhood cancer: 50 years of research collaboration, a report from the Children's Oncology Group

24 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.2

New approaches to molecular cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.2

Mutation-associated fusion cancer genes in solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.2

Cancer driver mutations in protein kinase genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.2

Cancer genes and the pathways they control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.2

Molecular targets for cancer chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.2

Molecular circuits of solid tumors: prognostic and predictive tools for bedside use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.2

The molecular pathology of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.2

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.2

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.2

Predictive biomarkers for personalised anti-cancer drug use: discovery to clinical implementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.2

Strategies for discovering novel cancer biomarkers through utilization of emerging technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.2

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.2

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.2

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.2

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.2

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.2

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.2

Strategies for molecular imaging of epidermal growth factor receptor tyrosine kinase in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.2

Comparison of 201Tl-chloride SPECT with 99mtc-MIBI SPECT in the depiction of malignant head and neck tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.2

Clinical value of planar and tomographic dual-isotope scintigraphy using 99mTc-methylene diphosphonate and 131I in patients with thyroid cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.2

Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.2

Next generation oncology drug development: opportunities and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.2

Bayesian adaptive design for targeted therapy development in lung cancer--a step toward personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.2

Regulatory agency consideration of pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.2

Regulatory and reimbursement challenges for molecular imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.2

Food and Drug Administration requirements for testing and approval of new radiopharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.2

Radiosynthesis and initial in vitro evaluation of [18F]F-PEG6-IPQA--a novel PET radiotracer for imaging EGFR expression-activity in lung carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.2

Molecular imaging of cancer: MR spectroscopy and beyond

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.2

Target-cancer-cell-specific activatable fluorescence imaging probes: rational design and in vivo applications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.2

31 March 2020

1 reference

https://pubmed.ncbi.nlm.nih.gov/21364686

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The BATTLE trial: personalizing therapy for lung cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21364686

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Tumor heterogeneity and the biology of cancer invasion and metastasis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21364686

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRCLINONC.2011.2

1 reference

24 August 2017

1 reference